

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.97627801 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.97627801 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.78011344 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.78011344 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.66624001 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.36270505 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.36270505 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.36270505 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.34033169 |
| 10 | urea metabolic process (GO:0019627) | 5.23810073 |
| 11 | urea cycle (GO:0000050) | 5.23810073 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.19347415 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.16952492 |
| 14 | cysteine metabolic process (GO:0006534) | 5.00841650 |
| 15 | glyoxylate metabolic process (GO:0046487) | 4.99265578 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 4.95374810 |
| 17 | bile acid biosynthetic process (GO:0006699) | 4.89360806 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.86296398 |
| 19 | nitrogen cycle metabolic process (GO:0071941) | 4.74453701 |
| 20 | homocysteine metabolic process (GO:0050667) | 4.74130863 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.72652321 |
| 22 | protein carboxylation (GO:0018214) | 4.71962346 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.71962346 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.70768000 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.68526915 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 4.65786002 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 4.65786002 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.62430596 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.60555747 |
| 30 | lysine metabolic process (GO:0006553) | 4.49871367 |
| 31 | lysine catabolic process (GO:0006554) | 4.49871367 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.40845564 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.39002056 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.38639191 |
| 35 | regulation of complement activation (GO:0030449) | 4.36724965 |
| 36 | DNA unwinding involved in DNA replication (GO:0006268) | 4.35144334 |
| 37 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.34483195 |
| 38 | nuclear pore complex assembly (GO:0051292) | 4.32074664 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.30472340 |
| 40 | mitotic chromosome condensation (GO:0007076) | 4.29176473 |
| 41 | phospholipid efflux (GO:0033700) | 4.23611128 |
| 42 | reverse cholesterol transport (GO:0043691) | 4.22303184 |
| 43 | bile acid metabolic process (GO:0008206) | 4.19145208 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.19019576 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 4.19019576 |
| 46 | glycine metabolic process (GO:0006544) | 4.18995535 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.13102229 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.13102229 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.13102229 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 4.09854365 |
| 51 | protein retention in ER lumen (GO:0006621) | 4.05835433 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.03225934 |
| 53 | serine family amino acid metabolic process (GO:0009069) | 3.98791984 |
| 54 | serine family amino acid biosynthetic process (GO:0009070) | 3.98051673 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 3.95035495 |
| 56 | bile acid and bile salt transport (GO:0015721) | 3.90289905 |
| 57 | pinocytosis (GO:0006907) | 3.86822672 |
| 58 | tyrosine metabolic process (GO:0006570) | 3.86517831 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 3.84156297 |
| 60 | urate metabolic process (GO:0046415) | 3.83555806 |
| 61 | acylglycerol homeostasis (GO:0055090) | 3.77094976 |
| 62 | triglyceride homeostasis (GO:0070328) | 3.77094976 |
| 63 | ethanol oxidation (GO:0006069) | 3.74393355 |
| 64 | drug catabolic process (GO:0042737) | 3.74182885 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 3.71253709 |
| 66 | cellular glucuronidation (GO:0052695) | 3.70625798 |
| 67 | cholesterol efflux (GO:0033344) | 3.68282516 |
| 68 | nuclear pore organization (GO:0006999) | 3.67676613 |
| 69 | fibrinolysis (GO:0042730) | 3.67269756 |
| 70 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65950013 |
| 71 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65950013 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 3.63408039 |
| 73 | drug transmembrane transport (GO:0006855) | 3.59940262 |
| 74 | phospholipid homeostasis (GO:0055091) | 3.58263382 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 3.56564775 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.54342204 |
| 77 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.53860307 |
| 78 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.53860307 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.53560956 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.51765742 |
| 81 | lipoprotein metabolic process (GO:0042157) | 3.50411014 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.47384166 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.47304354 |
| 84 | amine catabolic process (GO:0009310) | 3.47304354 |
| 85 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.46938751 |
| 86 | glutamate metabolic process (GO:0006536) | 3.46262920 |
| 87 | cellular ketone body metabolic process (GO:0046950) | 3.43564720 |
| 88 | cholesterol homeostasis (GO:0042632) | 3.43413161 |
| 89 | establishment of integrated proviral latency (GO:0075713) | 3.41628966 |
| 90 | sterol homeostasis (GO:0055092) | 3.41028502 |
| 91 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.38554203 |
| 92 | protein-lipid complex assembly (GO:0065005) | 3.38430577 |
| 93 | DNA strand elongation (GO:0022616) | 3.38198673 |
| 94 | carnitine metabolic process (GO:0009437) | 3.37886357 |
| 95 | mitotic sister chromatid segregation (GO:0000070) | 3.37484399 |
| 96 | low-density lipoprotein particle remodeling (GO:0034374) | 3.36839930 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.35244035 |
| 98 | aldehyde catabolic process (GO:0046185) | 3.35021509 |
| 99 | cell adhesion mediated by integrin (GO:0033627) | 3.33647860 |
| 100 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.32945659 |
| 101 | glucuronate metabolic process (GO:0019585) | 3.32224481 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.32224481 |
| 103 | skin morphogenesis (GO:0043589) | 3.31816389 |
| 104 | proline biosynthetic process (GO:0006561) | 3.30265290 |
| 105 | sister chromatid segregation (GO:0000819) | 3.29069986 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.27646718 |
| 107 | DNA topological change (GO:0006265) | 3.27513273 |
| 108 | protein localization to chromosome, centromeric region (GO:0071459) | 3.27291481 |
| 109 | 2-oxoglutarate metabolic process (GO:0006103) | 3.23805719 |
| 110 | coenzyme catabolic process (GO:0009109) | 3.23330249 |
| 111 | regulation of plasminogen activation (GO:0010755) | 3.22444513 |
| 112 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.21703434 |
| 113 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.21703434 |
| 114 | mitotic metaphase plate congression (GO:0007080) | 3.21381428 |
| 115 | protein maturation by protein folding (GO:0022417) | 3.21020874 |
| 116 | drug transport (GO:0015893) | 3.20823004 |
| 117 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.19232963 |
| 118 | arginine metabolic process (GO:0006525) | 3.17109510 |
| 119 | complement activation (GO:0006956) | 3.17062155 |
| 120 | pore complex assembly (GO:0046931) | 3.15910457 |
| 121 | protein-lipid complex subunit organization (GO:0071825) | 3.15450858 |
| 122 | complement activation, classical pathway (GO:0006958) | 3.14465658 |
| 123 | primary alcohol catabolic process (GO:0034310) | 3.13266073 |
| 124 | ethanol metabolic process (GO:0006067) | 3.13032904 |
| 125 | hypotonic response (GO:0006971) | 3.11014185 |
| 126 | protein localization to kinetochore (GO:0034501) | 3.01387844 |
| 127 | COPII vesicle coating (GO:0048208) | 3.01242102 |
| 128 | hepatocyte differentiation (GO:0070365) | 2.89512838 |
| 129 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.85264513 |
| 130 | telomere maintenance via recombination (GO:0000722) | 2.84676079 |
| 131 | hemidesmosome assembly (GO:0031581) | 2.84053263 |
| 132 | regulation of mitotic spindle organization (GO:0060236) | 2.82695046 |
| 133 | mitotic recombination (GO:0006312) | 2.81381028 |
| 134 | mitotic sister chromatid cohesion (GO:0007064) | 2.79218731 |
| 135 | ribosome assembly (GO:0042255) | 2.77876151 |
| 136 | metaphase plate congression (GO:0051310) | 2.76578803 |
| 137 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.75812663 |
| 138 | establishment of chromosome localization (GO:0051303) | 2.73128927 |
| 139 | protein hydroxylation (GO:0018126) | 2.70283616 |
| 140 | mitotic nuclear envelope disassembly (GO:0007077) | 2.70159576 |
| 141 | chromosome condensation (GO:0030261) | 2.69901011 |
| 142 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.66855743 |
| 143 | formation of translation preinitiation complex (GO:0001731) | 2.66758790 |
| 144 | regulation of translational fidelity (GO:0006450) | 2.66651508 |
| 145 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.61299055 |
| 146 | hyaluronan catabolic process (GO:0030214) | 2.61157300 |
| 147 | pentose-phosphate shunt (GO:0006098) | 2.60176138 |
| 148 | regulation of spindle organization (GO:0090224) | 2.57763566 |
| 149 | NADPH regeneration (GO:0006740) | 2.57123535 |
| 150 | nuclear envelope disassembly (GO:0051081) | 2.52048214 |
| 151 | membrane disassembly (GO:0030397) | 2.52048214 |
| 152 | DNA replication initiation (GO:0006270) | 2.51440496 |
| 153 | DNA ligation (GO:0006266) | 2.49004868 |
| 154 | proline metabolic process (GO:0006560) | 2.46963876 |
| 155 | peptidyl-proline hydroxylation (GO:0019511) | 2.46222271 |
| 156 | positive regulation of nuclease activity (GO:0032075) | 2.45878995 |
| 157 | DNA duplex unwinding (GO:0032508) | 2.43725682 |
| 158 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.42836750 |
| 159 | establishment of viral latency (GO:0019043) | 2.42512843 |
| 160 | peptidyl-asparagine modification (GO:0018196) | 2.42252369 |
| 161 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.42109598 |
| 162 | heterochromatin organization (GO:0070828) | 2.36600644 |
| 163 | DNA conformation change (GO:0071103) | 2.36407884 |
| 164 | glucose catabolic process (GO:0006007) | 2.35466630 |
| 165 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.34046472 |
| 166 | regulation of sister chromatid cohesion (GO:0007063) | 2.33892654 |
| 167 | DNA geometric change (GO:0032392) | 2.32680199 |
| 168 | regulation of apoptotic cell clearance (GO:2000425) | 2.32253321 |
| 169 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.31699395 |
| 170 | regulation of translational termination (GO:0006449) | 2.31295870 |
| 171 | vesicle coating (GO:0006901) | 2.29835662 |
| 172 | mesodermal cell differentiation (GO:0048333) | 2.29345872 |
| 173 | endodermal cell differentiation (GO:0035987) | 2.28945619 |
| 174 | DNA packaging (GO:0006323) | 2.28775880 |
| 175 | desmosome organization (GO:0002934) | 2.28521022 |
| 176 | protein N-linked glycosylation (GO:0006487) | 2.27617574 |
| 177 | negative regulation of protein activation cascade (GO:2000258) | 2.27149141 |
| 178 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.26935312 |
| 179 | positive regulation of extracellular matrix organization (GO:1903055) | 2.26472701 |
| 180 | positive regulation of chromosome segregation (GO:0051984) | 2.26120469 |
| 181 | hyaluronan metabolic process (GO:0030212) | 2.24784494 |
| 182 | embryonic process involved in female pregnancy (GO:0060136) | 2.23911449 |
| 183 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.21388365 |
| 184 | non-recombinational repair (GO:0000726) | 2.21388365 |
| 185 | basement membrane organization (GO:0071711) | 2.21135219 |
| 186 | negative regulation of DNA repair (GO:0045738) | 2.19522052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.92098039 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28639175 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.64437213 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.98243965 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.81693202 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.09111463 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.91285333 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.32965502 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.29826054 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.06232661 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75558354 |
| 12 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.66836328 |
| 13 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.65606602 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.56239248 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.49561456 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.15046822 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.11859345 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.11280042 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.04617939 |
| 20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.03942776 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02328350 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.97352921 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.93986476 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.93598393 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.93401999 |
| 26 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.91942387 |
| 27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.91188001 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84187110 |
| 29 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.81705414 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81554121 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76200511 |
| 32 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.74731607 |
| 33 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72895579 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72018277 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.70996784 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68243553 |
| 37 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.67269475 |
| 38 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.65803345 |
| 39 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.65639604 |
| 40 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.64854297 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64534927 |
| 42 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.60417436 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.55183955 |
| 44 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54231055 |
| 45 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.54070232 |
| 46 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51446172 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49632745 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48050458 |
| 49 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.46859510 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.44936933 |
| 51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41393439 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38334047 |
| 53 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38289228 |
| 54 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37115634 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35554002 |
| 56 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.30063909 |
| 57 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29940001 |
| 58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29582543 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27760134 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26638138 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25743895 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25108714 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25092102 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.24993104 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24674771 |
| 66 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.22996772 |
| 67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.22289968 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21064621 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20220352 |
| 70 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.19813182 |
| 71 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.19257342 |
| 72 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19177986 |
| 73 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.18862057 |
| 74 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.18500301 |
| 75 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17677850 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17264808 |
| 77 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.13560107 |
| 78 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13488852 |
| 79 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.13426554 |
| 80 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12698063 |
| 81 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10707981 |
| 82 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.09670349 |
| 83 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09310796 |
| 84 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.08742733 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06062751 |
| 86 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05839695 |
| 87 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05492782 |
| 88 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05479499 |
| 89 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05127055 |
| 90 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03636160 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02801326 |
| 92 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.01824803 |
| 93 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01641564 |
| 94 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01497727 |
| 95 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.01326479 |
| 96 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01242357 |
| 97 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00326075 |
| 98 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99862183 |
| 99 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99390608 |
| 100 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.99318798 |
| 101 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99167138 |
| 102 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98753626 |
| 103 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98243851 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97629551 |
| 105 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96925407 |
| 106 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96731787 |
| 107 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.96249852 |
| 108 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95020346 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94876978 |
| 110 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92878213 |
| 111 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91428314 |
| 112 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84842998 |
| 113 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84280984 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81587181 |
| 115 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.81489556 |
| 116 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.81170111 |
| 117 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80419387 |
| 118 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.80388384 |
| 119 | MYC_22102868_ChIP-Seq_BL_Human | 0.79583963 |
| 120 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79240161 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77534351 |
| 122 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77104694 |
| 123 | MAF_26560356_Chip-Seq_TH1_Human | 0.75677117 |
| 124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75153220 |
| 125 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.74835049 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74231652 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74078816 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72971901 |
| 129 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.72477364 |
| 130 | MYB_26560356_Chip-Seq_TH1_Human | 0.72387100 |
| 131 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.71602164 |
| 132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71583636 |
| 133 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.71254386 |
| 134 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70795312 |
| 135 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.70641989 |
| 136 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70174097 |
| 137 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.68632122 |
| 138 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.68526571 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68344556 |
| 140 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68081736 |
| 141 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.67515740 |
| 142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67424171 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.65910795 |
| 144 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.65224776 |
| 145 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64673260 |
| 146 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64453047 |
| 147 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63803273 |
| 148 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.62491858 |
| 149 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.62491858 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.61885198 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61285971 |
| 152 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.58972116 |
| 153 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.58437585 |
| 154 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58424792 |
| 155 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.58120490 |
| 156 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.58052527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.65421122 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.45731628 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.86855008 |
| 4 | MP0005365_abnormal_bile_salt | 4.76476633 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.11916595 |
| 6 | MP0003252_abnormal_bile_duct | 3.44661414 |
| 7 | MP0009840_abnormal_foam_cell | 3.13529381 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.11988636 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.89764701 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.73548291 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.65327784 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.53597347 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.44623909 |
| 14 | MP0004272_abnormal_basement_membrane | 2.36575935 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.36360591 |
| 16 | MP0005332_abnormal_amino_acid | 2.31342264 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.25910966 |
| 18 | MP0010094_abnormal_chromosome_stability | 2.17803684 |
| 19 | MP0005083_abnormal_biliary_tract | 2.12818718 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.08691842 |
| 21 | MP0004957_abnormal_blastocyst_morpholog | 2.03226088 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.00724672 |
| 23 | MP0000609_abnormal_liver_physiology | 1.98347454 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.95234713 |
| 25 | MP0003195_calcinosis | 1.92993055 |
| 26 | MP0008007_abnormal_cellular_replicative | 1.85057320 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.74932144 |
| 28 | MP0003077_abnormal_cell_cycle | 1.74225508 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 1.70631470 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.65800095 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.64927485 |
| 32 | MP0003941_abnormal_skin_development | 1.58609779 |
| 33 | MP0008932_abnormal_embryonic_tissue | 1.57581179 |
| 34 | MP0003436_decreased_susceptibility_to | 1.56523560 |
| 35 | MP0001730_embryonic_growth_arrest | 1.43050424 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.41153315 |
| 37 | MP0003186_abnormal_redox_activity | 1.39245860 |
| 38 | MP0009697_abnormal_copulation | 1.38452293 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.33890802 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26768505 |
| 41 | MP0000598_abnormal_liver_morphology | 1.25744515 |
| 42 | MP0005409_darkened_coat_color | 1.25235364 |
| 43 | MP0000350_abnormal_cell_proliferation | 1.24088594 |
| 44 | MP0002796_impaired_skin_barrier | 1.23216811 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.22910046 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.22038885 |
| 47 | MP0008057_abnormal_DNA_replication | 1.20564812 |
| 48 | MP0001764_abnormal_homeostasis | 1.20015510 |
| 49 | MP0004264_abnormal_extraembryonic_tissu | 1.18301582 |
| 50 | MP0002254_reproductive_system_inflammat | 1.15566967 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.13622958 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.13580083 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.11942156 |
| 54 | MP0001672_abnormal_embryogenesis/_devel | 1.11147125 |
| 55 | MP0005380_embryogenesis_phenotype | 1.11147125 |
| 56 | MP0003868_abnormal_feces_composition | 1.11060078 |
| 57 | MP0002086_abnormal_extraembryonic_tissu | 1.10659004 |
| 58 | MP0009764_decreased_sensitivity_to | 1.10333153 |
| 59 | MP0008469_abnormal_protein_level | 1.09573870 |
| 60 | MP0008260_abnormal_autophagy | 1.09269639 |
| 61 | MP0001835_abnormal_antigen_presentation | 1.08536216 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.06759462 |
| 63 | MP0002080_prenatal_lethality | 1.06754462 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.06731489 |
| 65 | MP0008058_abnormal_DNA_repair | 1.06384021 |
| 66 | MP0000467_abnormal_esophagus_morphology | 1.05885435 |
| 67 | MP0003091_abnormal_cell_migration | 1.05751625 |
| 68 | MP0001697_abnormal_embryo_size | 1.04131775 |
| 69 | MP0003984_embryonic_growth_retardation | 1.03586088 |
| 70 | MP0005621_abnormal_cell_physiology | 1.03539197 |
| 71 | MP0000858_altered_metastatic_potential | 1.02490681 |
| 72 | MP0001958_emphysema | 0.99526460 |
| 73 | MP0009763_increased_sensitivity_to | 0.99483282 |
| 74 | MP0003718_maternal_effect | 0.98007759 |
| 75 | MP0002088_abnormal_embryonic_growth/wei | 0.97345073 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 0.96133883 |
| 77 | MP0010030_abnormal_orbit_morphology | 0.96117017 |
| 78 | MP0004947_skin_inflammation | 0.95330869 |
| 79 | MP0000604_amyloidosis | 0.93085247 |
| 80 | MP0001849_ear_inflammation | 0.92652835 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.91762447 |
| 82 | MP0003303_peritoneal_inflammation | 0.91330071 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.89414753 |
| 84 | MP0005164_abnormal_response_to | 0.89278428 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.88555995 |
| 86 | MP0003943_abnormal_hepatobiliary_system | 0.88109787 |
| 87 | MP0003279_aneurysm | 0.87877142 |
| 88 | MP0000762_abnormal_tongue_morphology | 0.87122593 |
| 89 | MP0002060_abnormal_skin_morphology | 0.86936124 |
| 90 | MP0002419_abnormal_innate_immunity | 0.85931385 |
| 91 | MP0004233_abnormal_muscle_weight | 0.85524341 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.85105750 |
| 93 | MP0005384_cellular_phenotype | 0.85004885 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.84767510 |
| 95 | MP0006054_spinal_hemorrhage | 0.84693989 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.82658784 |
| 97 | MP0005023_abnormal_wound_healing | 0.81243529 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.80909234 |
| 99 | MP0001853_heart_inflammation | 0.80320889 |
| 100 | MP0004197_abnormal_fetal_growth/weight/ | 0.80238947 |
| 101 | MP0005197_abnormal_uvea_morphology | 0.80051121 |
| 102 | MP0009785_altered_susceptibility_to | 0.79262665 |
| 103 | MP0002084_abnormal_developmental_patter | 0.79029268 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.78182770 |
| 105 | MP0003011_delayed_dark_adaptation | 0.77973871 |
| 106 | MP0005025_abnormal_response_to | 0.77269133 |
| 107 | MP0005165_increased_susceptibility_to | 0.77234127 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.76558031 |
| 109 | MP0000627_abnormal_mammary_gland | 0.76313821 |
| 110 | MP0000358_abnormal_cell_content/ | 0.75906862 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.75812642 |
| 112 | MP0005451_abnormal_body_composition | 0.75732511 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.75628292 |
| 114 | MP0002085_abnormal_embryonic_tissue | 0.75511072 |
| 115 | MP0003315_abnormal_perineum_morphology | 0.75472708 |
| 116 | MP0000685_abnormal_immune_system | 0.74962415 |
| 117 | MP0005395_other_phenotype | 0.74215899 |
| 118 | MP0005408_hypopigmentation | 0.74200952 |
| 119 | MP0001873_stomach_inflammation | 0.74003981 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.73944694 |
| 121 | MP0005647_abnormal_sex_gland | 0.73162787 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.72580469 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.72057483 |
| 124 | MP0001756_abnormal_urination | 0.71954486 |
| 125 | MP0003724_increased_susceptibility_to | 0.71572146 |
| 126 | MP0001533_abnormal_skeleton_physiology | 0.71391166 |
| 127 | MP0005501_abnormal_skin_physiology | 0.71189884 |
| 128 | MP0009053_abnormal_anal_canal | 0.70542760 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 0.69635537 |
| 130 | MP0001545_abnormal_hematopoietic_system | 0.69635537 |
| 131 | MP0002928_abnormal_bile_duct | 0.68188196 |
| 132 | MP0005275_abnormal_skin_tensile | 0.66858841 |
| 133 | MP0008438_abnormal_cutaneous_collagen | 0.65987117 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.64890267 |
| 135 | MP0010155_abnormal_intestine_physiology | 0.64323896 |
| 136 | MP0010307_abnormal_tumor_latency | 0.63914310 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.62850486 |
| 138 | MP0001243_abnormal_dermal_layer | 0.61742105 |
| 139 | MP0001915_intracranial_hemorrhage | 0.61013358 |
| 140 | MP0002396_abnormal_hematopoietic_system | 0.59524187 |
| 141 | MP0003172_abnormal_lysosome_physiology | 0.58491749 |
| 142 | MP0000377_abnormal_hair_follicle | 0.58390729 |
| 143 | MP0010368_abnormal_lymphatic_system | 0.57334076 |
| 144 | MP0008873_increased_physiological_sensi | 0.56553082 |
| 145 | MP0005076_abnormal_cell_differentiation | 0.56309438 |
| 146 | MP0005334_abnormal_fat_pad | 0.55842197 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.55657845 |
| 148 | MP0001881_abnormal_mammary_gland | 0.54730401 |
| 149 | MP0009931_abnormal_skin_appearance | 0.53722388 |
| 150 | MP0006082_CNS_inflammation | 0.52951901 |
| 151 | MP0002971_abnormal_brown_adipose | 0.52088452 |
| 152 | MP0009384_cardiac_valve_regurgitation | 0.51335623 |
| 153 | MP0003075_altered_response_to | 0.51241556 |
| 154 | MP0004185_abnormal_adipocyte_glucose | 0.50521831 |
| 155 | MP0002135_abnormal_kidney_morphology | 0.50031808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.15261976 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.13215889 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.74330133 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.73910393 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.42974838 |
| 6 | Xanthomatosis (HP:0000991) | 5.38648518 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.99518810 |
| 8 | Complement deficiency (HP:0004431) | 4.68304587 |
| 9 | Premature rupture of membranes (HP:0001788) | 4.64240234 |
| 10 | Protrusio acetabuli (HP:0003179) | 4.50071960 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.40960520 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11816969 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.09517385 |
| 14 | Joint hemorrhage (HP:0005261) | 4.01511680 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.01507783 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.88242744 |
| 17 | Hyperammonemia (HP:0001987) | 3.84772655 |
| 18 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.81858911 |
| 19 | Abnormality of complement system (HP:0005339) | 3.71537006 |
| 20 | Fat malabsorption (HP:0002630) | 3.68984462 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.64978824 |
| 22 | Hyperglycinuria (HP:0003108) | 3.54542777 |
| 23 | Hyperglycinemia (HP:0002154) | 3.52973736 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.46170899 |
| 25 | Ketosis (HP:0001946) | 3.46079305 |
| 26 | Myocardial infarction (HP:0001658) | 3.45490322 |
| 27 | Epidermoid cyst (HP:0200040) | 3.44182743 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.43147257 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.43147257 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.39199823 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.36373389 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.25505209 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 3.24341732 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.20190131 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.19124849 |
| 36 | Vertebral compression fractures (HP:0002953) | 3.11417265 |
| 37 | Cervical subluxation (HP:0003308) | 3.07754766 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.02605643 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.02272378 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 3.02064251 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 3.02010693 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.95583143 |
| 43 | Ankle contracture (HP:0006466) | 2.91998623 |
| 44 | Abnormality of carpal bone ossification (HP:0006257) | 2.87671745 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.87225104 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83972655 |
| 47 | Flat acetabular roof (HP:0003180) | 2.82935933 |
| 48 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.80083667 |
| 49 | Hyperbilirubinemia (HP:0002904) | 2.77086576 |
| 50 | Gout (HP:0001997) | 2.73542066 |
| 51 | Steatorrhea (HP:0002570) | 2.71804414 |
| 52 | Spontaneous abortion (HP:0005268) | 2.68586729 |
| 53 | Abnormality of the acetabulum (HP:0003170) | 2.67586908 |
| 54 | Vascular calcification (HP:0004934) | 2.62672689 |
| 55 | Gingival bleeding (HP:0000225) | 2.60643078 |
| 56 | Spastic diplegia (HP:0001264) | 2.57814759 |
| 57 | Esophageal varix (HP:0002040) | 2.52154419 |
| 58 | Abnormal delivery (HP:0001787) | 2.51897274 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.49946842 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.49946842 |
| 61 | Abnormality of proline metabolism (HP:0010907) | 2.49524541 |
| 62 | Hydroxyprolinuria (HP:0003080) | 2.49524541 |
| 63 | Arterial tortuosity (HP:0005116) | 2.48327079 |
| 64 | Vascular tortuosity (HP:0004948) | 2.46647031 |
| 65 | Syringomyelia (HP:0003396) | 2.44297272 |
| 66 | Spinal cord lesions (HP:0100561) | 2.44297272 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.43597991 |
| 68 | Mitral stenosis (HP:0001718) | 2.43592990 |
| 69 | Abnormal ossification of hand bones (HP:0005921) | 2.43266714 |
| 70 | Chromsome breakage (HP:0040012) | 2.42989991 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.42819206 |
| 72 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.41919530 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.41446556 |
| 74 | Wormian bones (HP:0002645) | 2.40124201 |
| 75 | Atrophic scars (HP:0001075) | 2.37584719 |
| 76 | Acanthocytosis (HP:0001927) | 2.37540371 |
| 77 | Short nail (HP:0001799) | 2.36934002 |
| 78 | Ketoacidosis (HP:0001993) | 2.30939134 |
| 79 | Thrombophlebitis (HP:0004418) | 2.30134223 |
| 80 | Glomerulonephritis (HP:0000099) | 2.27367671 |
| 81 | Metabolic acidosis (HP:0001942) | 2.26869020 |
| 82 | Aortic dissection (HP:0002647) | 2.25228757 |
| 83 | Skin nodule (HP:0200036) | 2.24433874 |
| 84 | Malnutrition (HP:0004395) | 2.21903434 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.20121772 |
| 86 | Abnormality of dentin (HP:0010299) | 2.19403326 |
| 87 | Fragile skin (HP:0001030) | 2.14850352 |
| 88 | Microglossia (HP:0000171) | 2.14671369 |
| 89 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.13191085 |
| 90 | Increased mean platelet volume (HP:0011877) | 2.12703750 |
| 91 | Asymmetry of the thorax (HP:0001555) | 2.11274075 |
| 92 | Abnormal hand bone ossification (HP:0010660) | 2.09357771 |
| 93 | Menorrhagia (HP:0000132) | 2.08866589 |
| 94 | Hypophosphatemic rickets (HP:0004912) | 2.06909766 |
| 95 | Abnormal foot bone ossification (HP:0010675) | 2.06435742 |
| 96 | Blue sclerae (HP:0000592) | 2.05656873 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 2.05231700 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05231700 |
| 99 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.05219870 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02642008 |
| 101 | Back pain (HP:0003418) | 2.01630411 |
| 102 | Amyloidosis (HP:0011034) | 2.01123065 |
| 103 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.00976445 |
| 104 | Small epiphyses (HP:0010585) | 2.00610244 |
| 105 | Hypochromic microcytic anemia (HP:0004840) | 2.00412640 |
| 106 | Abnormality of skull ossification (HP:0002703) | 2.00408573 |
| 107 | Spinal rigidity (HP:0003306) | 2.00385928 |
| 108 | Decreased skull ossification (HP:0004331) | 2.00264516 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 2.00081621 |
| 110 | Neonatal onset (HP:0003623) | 1.98749302 |
| 111 | Abnormal platelet volume (HP:0011876) | 1.96661162 |
| 112 | Acute myeloid leukemia (HP:0004808) | 1.96374594 |
| 113 | Sensorimotor neuropathy (HP:0007141) | 1.96078132 |
| 114 | Natal tooth (HP:0000695) | 1.95385194 |
| 115 | Deviation of the thumb (HP:0009603) | 1.94447167 |
| 116 | Peritonitis (HP:0002586) | 1.94296604 |
| 117 | Ankyloglossia (HP:0010296) | 1.93940642 |
| 118 | Upper motor neuron abnormality (HP:0002127) | 1.93091973 |
| 119 | Elbow flexion contracture (HP:0002987) | 1.92600879 |
| 120 | Breech presentation (HP:0001623) | 1.92457591 |
| 121 | Pancreatitis (HP:0001733) | 1.92195493 |
| 122 | Axonal loss (HP:0003447) | 1.90255092 |
| 123 | Proximal tubulopathy (HP:0000114) | 1.90079931 |
| 124 | Increased purine levels (HP:0004368) | 1.88585142 |
| 125 | Hyperuricemia (HP:0002149) | 1.88585142 |
| 126 | Delayed cranial suture closure (HP:0000270) | 1.88378810 |
| 127 | Irritability (HP:0000737) | 1.88269214 |
| 128 | Late onset (HP:0003584) | 1.87738209 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 1.87453576 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.86881836 |
| 131 | Trismus (HP:0000211) | 1.85354438 |
| 132 | Impaired platelet aggregation (HP:0003540) | 1.84990675 |
| 133 | Abnormal platelet function (HP:0011869) | 1.84990675 |
| 134 | Thrombocytosis (HP:0001894) | 1.84695191 |
| 135 | Nephritis (HP:0000123) | 1.84514768 |
| 136 | Periodontitis (HP:0000704) | 1.83873192 |
| 137 | Soft skin (HP:0000977) | 1.82567659 |
| 138 | Ulnar bowing (HP:0003031) | 1.82089770 |
| 139 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.80565722 |
| 140 | Aortic aneurysm (HP:0004942) | 1.80548495 |
| 141 | Epistaxis (HP:0000421) | 1.80160236 |
| 142 | Neonatal short-limb short stature (HP:0008921) | 1.79886252 |
| 143 | Polycythemia (HP:0001901) | 1.79521635 |
| 144 | Vacuolated lymphocytes (HP:0001922) | 1.79081935 |
| 145 | Abnormality of the Achilles tendon (HP:0005109) | 1.78912239 |
| 146 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78889834 |
| 147 | Coxa vara (HP:0002812) | 1.78345290 |
| 148 | Hypoglycemic seizures (HP:0002173) | 1.78338538 |
| 149 | Biconcave vertebral bodies (HP:0004586) | 1.77914084 |
| 150 | Elevated alkaline phosphatase (HP:0003155) | 1.77810770 |
| 151 | Absent epiphyses (HP:0010577) | 1.76117165 |
| 152 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.76117165 |
| 153 | Lethargy (HP:0001254) | 1.75520904 |
| 154 | Spondylolisthesis (HP:0003302) | 1.75225844 |
| 155 | Nonimmune hydrops fetalis (HP:0001790) | 1.74016377 |
| 156 | Alkalosis (HP:0001948) | 1.72628614 |
| 157 | Poikilocytosis (HP:0004447) | 1.72535193 |
| 158 | Vertebral hypoplasia (HP:0008417) | 1.71202998 |
| 159 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.71202998 |
| 160 | Generalized amyotrophy (HP:0003700) | 1.71186687 |
| 161 | Abnormality of oral frenula (HP:0000190) | 1.69129163 |
| 162 | Pterygium (HP:0001059) | 1.68967051 |
| 163 | Spinal cord compression (HP:0002176) | 1.68299476 |
| 164 | Orthostatic hypotension (HP:0001278) | 1.66727750 |
| 165 | Abnormality of the umbilical cord (HP:0010881) | 1.66468156 |
| 166 | Capillary hemangiomas (HP:0005306) | 1.66441414 |
| 167 | Rough bone trabeculation (HP:0100670) | 1.64628520 |
| 168 | Proximal placement of thumb (HP:0009623) | 1.62985952 |
| 169 | Advanced eruption of teeth (HP:0006288) | 1.62520710 |
| 170 | Entropion (HP:0000621) | 1.58244613 |
| 171 | Achilles tendon contracture (HP:0001771) | 1.57940175 |
| 172 | Right ventricular cardiomyopathy (HP:0011663) | 1.57900147 |
| 173 | Joint laxity (HP:0001388) | 1.57806481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.63392739 |
| 2 | BCKDK | 3.89651248 |
| 3 | BUB1 | 2.82383449 |
| 4 | TAOK3 | 2.71364151 |
| 5 | MST1R | 2.65436415 |
| 6 | FLT3 | 2.61287719 |
| 7 | FGFR4 | 2.60858188 |
| 8 | SIK1 | 2.48957276 |
| 9 | TRIB3 | 2.38820468 |
| 10 | TYK2 | 2.21876565 |
| 11 | PKN2 | 2.20674265 |
| 12 | MAP3K14 | 2.05174156 |
| 13 | SMG1 | 1.93055306 |
| 14 | TBK1 | 1.91543454 |
| 15 | SRPK1 | 1.78308359 |
| 16 | PTK6 | 1.71046189 |
| 17 | EIF2AK3 | 1.67699254 |
| 18 | MAP3K3 | 1.60789775 |
| 19 | MAP2K3 | 1.58228701 |
| 20 | NEK9 | 1.57964806 |
| 21 | LATS1 | 1.52798799 |
| 22 | ACVR1B | 1.51653122 |
| 23 | RPS6KA4 | 1.50727376 |
| 24 | VRK2 | 1.46868665 |
| 25 | CDK6 | 1.41532203 |
| 26 | PIK3CG | 1.41074889 |
| 27 | ICK | 1.40426440 |
| 28 | CDK7 | 1.39734589 |
| 29 | STK10 | 1.37994599 |
| 30 | NME2 | 1.37765959 |
| 31 | MAPK11 | 1.35585077 |
| 32 | FRK | 1.34724325 |
| 33 | MAP3K10 | 1.32250605 |
| 34 | CSF1R | 1.32165463 |
| 35 | STK3 | 1.31515216 |
| 36 | LRRK2 | 1.30430302 |
| 37 | KIT | 1.29176498 |
| 38 | ERBB4 | 1.27866917 |
| 39 | CDK8 | 1.27455651 |
| 40 | SCYL2 | 1.26612144 |
| 41 | LATS2 | 1.23147264 |
| 42 | MET | 1.22503048 |
| 43 | BRSK2 | 1.21361760 |
| 44 | RPS6KB2 | 1.20695972 |
| 45 | NEK2 | 1.20033280 |
| 46 | PIM2 | 1.16002882 |
| 47 | PAK2 | 1.15225955 |
| 48 | PLK3 | 1.14351149 |
| 49 | NEK1 | 1.14020497 |
| 50 | CHEK2 | 1.11200890 |
| 51 | EEF2K | 1.10699865 |
| 52 | TSSK6 | 1.09599459 |
| 53 | GRK6 | 1.09416525 |
| 54 | ABL2 | 1.03531340 |
| 55 | TGFBR2 | 1.02734711 |
| 56 | JAK3 | 1.02038446 |
| 57 | MOS | 1.00282927 |
| 58 | MAP3K8 | 0.99675932 |
| 59 | BLK | 0.98185361 |
| 60 | BRSK1 | 0.97949183 |
| 61 | TESK1 | 0.95313222 |
| 62 | PLK1 | 0.94716283 |
| 63 | CDK4 | 0.93953882 |
| 64 | PAK4 | 0.89876370 |
| 65 | ZAP70 | 0.87415161 |
| 66 | BMX | 0.87221766 |
| 67 | MAP3K11 | 0.86706819 |
| 68 | JAK2 | 0.85878342 |
| 69 | WEE1 | 0.85184954 |
| 70 | MAP4K1 | 0.84406092 |
| 71 | PIM1 | 0.83674027 |
| 72 | RIPK1 | 0.83405793 |
| 73 | CLK1 | 0.82916963 |
| 74 | PLK4 | 0.81802774 |
| 75 | KDR | 0.81229507 |
| 76 | DYRK1B | 0.81132477 |
| 77 | JAK1 | 0.80757694 |
| 78 | BRD4 | 0.78863859 |
| 79 | CDK12 | 0.78488209 |
| 80 | EIF2AK2 | 0.77959821 |
| 81 | CHEK1 | 0.77333003 |
| 82 | MELK | 0.77330969 |
| 83 | IRAK3 | 0.75520755 |
| 84 | STK38L | 0.73768738 |
| 85 | EIF2AK1 | 0.73728981 |
| 86 | CSK | 0.72469959 |
| 87 | TTK | 0.72071177 |
| 88 | IKBKE | 0.70611366 |
| 89 | MATK | 0.68008398 |
| 90 | ARAF | 0.67721043 |
| 91 | BTK | 0.67139443 |
| 92 | TESK2 | 0.64225604 |
| 93 | EPHB1 | 0.63808911 |
| 94 | TGFBR1 | 0.62014643 |
| 95 | MKNK1 | 0.61024167 |
| 96 | CDK9 | 0.59980479 |
| 97 | IKBKB | 0.59558172 |
| 98 | LIMK1 | 0.59418623 |
| 99 | CHUK | 0.59162277 |
| 100 | MAPKAPK3 | 0.58952029 |
| 101 | PDK3 | 0.56410612 |
| 102 | PDK4 | 0.56410612 |
| 103 | AURKA | 0.55232784 |
| 104 | PRKAA2 | 0.54664807 |
| 105 | YES1 | 0.54557742 |
| 106 | LMTK2 | 0.52750279 |
| 107 | PRKG2 | 0.51333925 |
| 108 | PTK2 | 0.51288089 |
| 109 | STK4 | 0.49964581 |
| 110 | MTOR | 0.49483684 |
| 111 | MAPK4 | 0.49181605 |
| 112 | MYLK | 0.48856053 |
| 113 | CAMK1D | 0.48162200 |
| 114 | TTN | 0.47309041 |
| 115 | MST4 | 0.45859687 |
| 116 | FGFR1 | 0.45663233 |
| 117 | MAP3K6 | 0.44647270 |
| 118 | EGFR | 0.44400385 |
| 119 | ATM | 0.44152048 |
| 120 | EPHB2 | 0.43868296 |
| 121 | NTRK1 | 0.43707329 |
| 122 | MAPKAPK2 | 0.43293099 |
| 123 | MAP3K5 | 0.42926776 |
| 124 | RAF1 | 0.42624996 |
| 125 | TRIM28 | 0.42319918 |
| 126 | MAP3K2 | 0.41814804 |
| 127 | TRPM7 | 0.41382763 |
| 128 | CDC7 | 0.40965430 |
| 129 | STK16 | 0.40378808 |
| 130 | FGFR3 | 0.39910619 |
| 131 | PDGFRA | 0.39727983 |
| 132 | EPHA2 | 0.38672478 |
| 133 | PDGFRB | 0.38172288 |
| 134 | PAK1 | 0.37948277 |
| 135 | AURKB | 0.37912501 |
| 136 | PBK | 0.37744703 |
| 137 | SIK3 | 0.37716046 |
| 138 | GSK3A | 0.36673156 |
| 139 | ABL1 | 0.36319430 |
| 140 | TEC | 0.35877811 |
| 141 | ITK | 0.34813644 |
| 142 | MAP2K2 | 0.34571350 |
| 143 | ATR | 0.33998122 |
| 144 | IRAK4 | 0.33867141 |
| 145 | FER | 0.33865444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03623333 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.43358243 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20210834 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13870262 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.86158130 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62363021 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52722711 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.51102645 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46534940 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42652528 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 2.33793870 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33319011 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.23296545 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16591038 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14854069 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 2.04243490 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.99351246 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.96435645 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89879397 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.89878164 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87431717 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.84682928 |
| 23 | Cell cycle_Homo sapiens_hsa04110 | 1.82310792 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77554559 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.77111626 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75990795 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71250160 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.70779190 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.69053133 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62277294 |
| 31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.59340837 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58575598 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56080644 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54106766 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52788533 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.50675090 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.49441054 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44657629 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.44411322 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43473860 |
| 41 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40948789 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37598760 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35686462 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34281975 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.32729346 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.32199525 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31346127 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31070915 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.29908357 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27102906 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 1.23161293 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22726757 |
| 53 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.21475585 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20007926 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.19557001 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17477398 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08653972 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08410175 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08108591 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04718499 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04342021 |
| 62 | Proteasome_Homo sapiens_hsa03050 | 1.01177634 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00790339 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97873236 |
| 65 | Spliceosome_Homo sapiens_hsa03040 | 0.97829281 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95383831 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92802999 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90974806 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90898985 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89841470 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89464584 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89297789 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88557390 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88192935 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.88020860 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.87658423 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84085674 |
| 78 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84046115 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83994867 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.83813096 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83800925 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83585501 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82795446 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81960145 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79763620 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.76006387 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.73422098 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.72455898 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71327331 |
| 90 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71306931 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.68967322 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68664759 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62388018 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55842918 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53337612 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49927971 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48662338 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48392575 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47513125 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.44513055 |
| 101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44443233 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44132898 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44100328 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43400116 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43252036 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43152285 |
| 107 | Legionellosis_Homo sapiens_hsa05134 | 0.42237234 |
| 108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40401401 |
| 109 | Purine metabolism_Homo sapiens_hsa00230 | 0.40154209 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36095278 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35983957 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35858511 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33592624 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.30797308 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.28342871 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26555247 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.15657205 |
| 118 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.15449168 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.14655474 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.13728373 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11902206 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.11133339 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.10998696 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.08815887 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.08520116 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.06712437 |
| 127 | Other glycan degradation_Homo sapiens_hsa00511 | 0.05669093 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.04023700 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03135020 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02472080 |
| 131 | Leishmaniasis_Homo sapiens_hsa05140 | 0.02099556 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01420281 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00645491 |
| 134 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.00047667 |
| 135 | Apoptosis_Homo sapiens_hsa04210 | -0.0342299 |
| 136 | DNA replication_Homo sapiens_hsa03030 | -0.0295433 |
| 137 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0046460 |
| 138 | Influenza A_Homo sapiens_hsa05164 | -0.0015052 |

